BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 35955664)

  • 21. Retinopathy of prematurity.
    Chen J; Smith LE
    Angiogenesis; 2007; 10(2):133-40. PubMed ID: 17332988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinopathy of Prematurity: A Global Perspective and Recent Developments.
    Sabri K; Ells AL; Lee EY; Dutta S; Vinekar A
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35948728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin is not a risk factor for severe retinopathy of prematurity among high risk preterm infants.
    Bui KCT; Ellenhorn N; Abbasi A; Villosis MFB; Nguyen M; Truong H; Watson T; Buchanan J; Chen Q
    Early Hum Dev; 2021 Oct; 161():105440. PubMed ID: 34407495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of retinopathy of prematurity.
    Reynolds JD
    Paediatr Drugs; 2001; 3(4):263-72. PubMed ID: 11354698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinopathy of prematurity.
    Jordan CO
    Pediatr Clin North Am; 2014 Jun; 61(3):567-77. PubMed ID: 24852153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Standardize the laser and anti-vascular endothelial growth factor treatment of retinopathy of prematurity].
    Zhang GM; Tian RY
    Zhonghua Yan Ke Za Zhi; 2023 Mar; 59(3):169-173. PubMed ID: 36860102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.
    Aranda JV; Qu J; Valencia GB; Beharry KD
    Semin Perinatol; 2019 Oct; 43(6):360-366. PubMed ID: 31153620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.
    Lofqvist C; Chen J; Connor KM; Smith AC; Aderman CM; Liu N; Pintar JE; Ludwig T; Hellstrom A; Smith LE
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10589-94. PubMed ID: 17567756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
    Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
    Huang ZN; Yin DM; Huang DR; Liang SX
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can We Stop the Current Epidemic of Blindness From Retinopathy of Prematurity?
    Dutta S; Raghuveer T; Vinekar A; Dogra MR
    Indian Pediatr; 2016 Nov; 53 Suppl 2():S80-S84. PubMed ID: 27915311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Cytokines in Retinopathy of Prematurity.
    Wu PY; Fu YK; Lien RI; Chiang MC; Lee CC; Chen HC; Hsueh YJ; Chen KJ; Wang NK; Liu L; Chen YP; Hwang YS; Lai CC; Wu WC
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinopathy of prematurity: a study of prevalence and risk factors.
    Hakeem AH; Mohamed GB; Othman MF
    Middle East Afr J Ophthalmol; 2012; 19(3):289-94. PubMed ID: 22837621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of retinopathy of prematurity and possible preventive strategies.
    Fleck BW; McIntosh N
    Early Hum Dev; 2008 Feb; 84(2):83-8. PubMed ID: 18234458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The progress of prophylactic treatment in retinopathy of prematurity.
    Zhang HB; Wang XD; Xu K; Li XG
    Int J Ophthalmol; 2018; 11(5):858-873. PubMed ID: 29862189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of retinopathy of prematurity treatment in extremely preterm infants in China.
    Dai Y; Zhu L; Zhou Y; Wu Y; Chen D; Wang R; Wu L; Guo S; Gao L; Xu P; Wang Y; Dong S; Liu N; Wu Y; Chen H; Sun Y; Chen C; Zhang S
    Paediatr Perinat Epidemiol; 2022 May; 36(3):380-389. PubMed ID: 34467552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening Examination of Premature Infants for Retinopathy of Prematurity.
    Fierson WM; ; ; ;
    Pediatrics; 2018 Dec; 142(6):. PubMed ID: 30478242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding retinopathy of prematurity: update on pathogenesis.
    Rivera JC; Sapieha P; Joyal JS; Duhamel F; Shao Z; Sitaras N; Picard E; Zhou E; Lachapelle P; Chemtob S
    Neonatology; 2011; 100(4):343-53. PubMed ID: 21968165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Retinopathy of prematurity: from prevention to treatment].
    Daruich A; Bremond-Gignac D; Behar-Cohen F; Kermorvant E
    Med Sci (Paris); 2020 Oct; 36(10):900-907. PubMed ID: 33026333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.